ardelyx
An Associate Director, Process Chemistry at Ardelyx leads small-molecule process development and manufacturing for clinical-stage drug substance programs, focusing on early-phase clinical manufacturing and technical oversight of synthetic routes.
Headquarters
Waltham, Massachusetts, United States
Company Size
201-500 employees
Founded
2007
Ardelyx is a biopharmaceutical company that discovers, develops, and commercializes first-in-class medicines for patients with unmet medical needs in gastrointestinal and cardiorenal diseases. The company markets IBSRELA (tenapanor) for irritable bowel syndrome with constipation (IBS-C) and XPHOZAH for chronic kidney disease with hyperphosphatemia, while also pursuing additional pipeline programs including chronic idiopathic constipation. Headquartered in Northern California, Ardelyx is committed to delivering novel-mechanism therapies that improve outcomes for patients with GI and kidney disorders.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for ardelyx.
Right around the average for this role
Chemist – Discovery Process Chemistry
Merck & Co., Inc.
Senior Scientist Chemistry (PhD)
AstraZeneca
Sr Scientist I (Process Chemistry)
Exelixis
Chemist – Discovery Process Chemistry
MSD
Senior Scientist II, Process Chemistry
Exelixis
Associate Director, CMC Synthetic Chemistry – Small Molecule
Beeline Medicines